|
TRIM25 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64168678651322E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.9831692671678E-13 |
| Normal-vs-Stage2 |
1.73634999999228E-05 |
| Normal-vs-Stage3 |
4.28850288614058E-11 |
| Normal-vs-Stage4 |
7.01320002072237E-10 |
| Stage1-vs-Stage2 |
2.023600E-01 |
| Stage1-vs-Stage3 |
2.769000E-01 |
| Stage1-vs-Stage4 |
2.198600E-01 |
| Stage2-vs-Stage3 |
8.082300E-02 |
| Stage2-vs-Stage4 |
5.959800E-02 |
| Stage3-vs-Stage4 |
7.513600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.67754699020861E-13 |
| Normal-vs-AfricanAmerican |
4.29690000003369E-06 |
| Normal-vs-Asian |
8.37590000000166E-05 |
| Caucasian-vs-AfricanAmerican |
9.817000E-01 |
| Caucasian-vs-Asian |
4.075600E-02 |
| AfricanAmerican-vs-Asian |
1.707180E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.65294469620403E-13 |
| Normal-vs-Female |
2.23476792626798E-12 |
| Male-vs-Female |
2.557800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.92703663926386E-12 |
| Normal-vs-Age(41-60Yrs) |
1.43249967443637E-10 |
| Normal-vs-Age(61-80Yrs) |
7.2517547522466E-12 |
| Normal-vs-Age(81-100Yrs) |
5.58859999999495E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.526600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.845400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.625430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.274200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.296400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.447000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.866020E-01 |
| Classical-VS-Follicular |
2.642000E-01 |
| Classical-VS-Other |
5.270300E-02 |
| Classical-VS-Normal |
3.66207064672608E-12 |
| Tall-VS-Follicular |
4.503800E-01 |
| Tall-VS-Other |
4.890000E-01 |
| Tall-VS-Normal |
4.58889999999101E-07 |
| Follicular-VS-Other |
1.330240E-01 |
| Follicular-VS-Normal |
1.35749966823084E-10 |
| Other-VS-Normal |
4.20010000000692E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.85749970960103E-10 |
| Normal-vs-N1 |
6.92557122761173E-13 |
| N0-vs-N1 |
9.840900E-03 |
|
|
